iShares MSCI USA Momentum Factor ETF

MTUM

Market cap $28.4B

A well-known momentum ETF is up 21% this year. But the smart investor knows every party eventually ends.

While momentum, growth, and high-beta strategies have served as the engines driving quarter-to-date returns for factor ETFs, a subtle shift under the hood suggests a potential factor rotation may be underway. Notably, the same sectors that have propelled the broad market higher this quarter encountered a sharp reversal over the past two trading sessions.

It isn't time to bail on the Magnificent Seven yet. But there are momentum winners in staples and healthcare, too.

The iShares MSCI USA Momentum Factor ETF offers concentrated exposure to large-cap momentum stocks, heavily overweighting technology and industrials. MTUM trades at a 7.1% P/E premium to the S&P 500, justified by superior historical earnings (18.5% vs. 10.1%) and sales growth. Performance is uneven year-to-year, with above-market volatility (3-year beta 1.26) and returns that are not tightly correlated with broad equity indexes.

iShares MSCI USA Momentum Factor ETF delivered a 12% YTD return, outperforming the S&P 500 by nearly 8%, and maintains a Buy rating. MTUM's strategy targets 120–130 stocks with high 6–12 month risk-adjusted momentum, rebalancing quarterly to manage risk and capture uptrends. The ETF is heavily weighted in technology (notably semiconductors and AI), industrials (especially aerospace & defense), and large diversified banks.

The momentum factor is alive and well, reaching levels of outperformance this month despite languishing for much of the first quarter. According to research data as of April 24, the underlying index in the Invesco S&P 500 Momentum ETF (SPMO) is having its best month since launching in November 2014.

Ceasefire extension lifts sentiment, but uncertainty lingers. Key ETFs react to oil moves, AI optimism and momentum trends amid fragile geopolitics.

I downgrade iShares MSCI USA Momentum Factor ETF to hold as momentum underperforms and technicals deteriorate. MTUM's tech-heavy portfolio, with over 40% in US tech, faces headwinds amid sector underperformance and broadening market leadership. Elevated P/E above 25x and soft February–March seasonality reduce near-term appeal despite strong long-term earnings growth.

The Investment Committee debate the software volatility and how you should position your portfolio.

5 ETFs to buy in January: momentum, small caps, chips, defense and healthcare shine as markets rally early in 2026 -- IWM, MTUM, SMH, XAR and IHE.